Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics Total Assets (Quarterly) : 11.81M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.81M |
| March 31, 2026 | 3.502M |
| December 31, 2025 | 5.42M |
| September 30, 2025 | 5.983M |
| Date | Value |
|---|---|
| June 30, 2025 | 3.543M |
| March 31, 2025 | 4.438M |
| December 31, 2024 | 5.468M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.873M |
| Shareholders Equity (Quarterly) | 10.94M |
| Current Ratio | 13.53 |